Additional file 1 of LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

van Tilburg, Cornelis M.; Kilburn, Lindsay B.; Perreault, Sébastien; Schmidt, Rene; Azizi, Amedeo A.; Cruz-Martínez, Ofelia; Zápotocký, Michal; Scheinemann, Katrin; Meeteren, Antoinette Y. N. Schouten-van; Sehested, Astrid; Opocher, Enrico; Driever, Pablo Hernáiz; Avula, Shivaram; Ziegler, David S.; Capper, David; Koch, Arend; Sahm, Felix; Qiu, Jiaheng; Tsao, Li-Pen; Blackman, Samuel C.; Manley, Peter; Milde, Till; Witt, Ruth; Jones, David T. W.; Hargrave, Darren; Witt, Olaf

doi:10.6084/m9.figshare.25115980.v1

12885_2024_11820_MOESM1_ESM.docx (21.23 kB)

Additional file 1 of LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

journal contribution

posted on 2024-01-31, 04:40 authored by Cornelis M. van Tilburg, Lindsay B. Kilburn, Sébastien Perreault, Rene Schmidt, Amedeo A. Azizi, Ofelia Cruz-Martínez, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten-van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li-Pen Tsao, Samuel C. Blackman, Peter Manley, Till Milde, Ruth Witt, David T. W. Jones, Darren Hargrave, Olaf Witt

Additional file 1.